Last updated: August 2, 2023
Sponsor: Assiut University
Overall Status: Active - Recruiting
Phase
4
Condition
Lung Disease
Pleural Effusion
Treatment
lidocaine 2.5% and prilocaine 2.5% cream in pain management before pleurocentesis.
Clinical Study ID
NCT05984264
BBBAAS
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All Patients will be prepared for pleurocentesis.
Exclusion
Exclusion Criteria:
- Patients with a known history of sensitivity to local anesthetics of the amide type orto any other component of the product.
- Patients treated with class III anti-arrhythmic drugs (e.g., amiodarone, bretylium,sotalol, dofetilide).
Study Design
Total Participants: 118
Treatment Group(s): 1
Primary Treatment: lidocaine 2.5% and prilocaine 2.5% cream in pain management before pleurocentesis.
Phase: 4
Study Start date:
January 01, 2023
Estimated Completion Date:
December 31, 2023
Study Description
Connect with a study center
Assuit University Hospital
Assiut, Assiut university 71515
EgyptActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.